Jiahui Li
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Hypothalamic Control of Liver Health and Disease: From Circuits to Pathophysiology and Therapies.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 02, 2026
A two-pronged nanomedicine counteracts obesity by remodeling adipose niche.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: September 16, 2025
TOX3 in hypothalamic POMC-lineage cells regulates energy balance via the PTEN-AKT signaling axis.
Journal: Nature communications
Published: September 05, 2025
Adipose TGR5 Deletion Promotes Hepatic Steatosis Through Decreasing Adiponectin Secretion in Mice.
Journal: Diabetes
Published: April 07, 2025
Tirzepatide reduces body weight by increasing fat utilization via the central nervous system-adipose tissue axis in male mice.
Journal: Diabetes, obesity & metabolism
Published: October 10, 2024
Reactive Oxygen Species-Responsive Delivery of a Notch Inhibitor to Alleviate Nonalcoholic Steatohepatitis by Inhibiting Hepatic de Novo Lipogenesis and Inflammation.
Journal: Molecular pharmaceutics
Published: May 16, 2024
Glutaredoxin-1 alleviates acetaminophen-induced liver injury by decreasing its toxic metabolites.
Journal: Journal of pharmaceutical analysis
Published: April 21, 2023
Glutaredoxin 1 regulates cholesterol metabolism and gallstone formation by influencing protein S-glutathionylation.
Journal: Metabolism: clinical and experimental
Published: April 06, 2023
Mesencephalic astrocyte-derived neurotrophic factor protects against paracetamol -induced liver injury by inhibiting PERK-ATF4-CHOP signaling pathway.
Journal: Biochemical and biophysical research communications
Published: February 11, 2022
Last Updated: 09/26/2026